LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(FY)Oct 27, 2024 | (Q4)Oct 27, 2024 | (Q3)Jul 28, 2024 | (Q2)Apr 28, 2024 | (Q1)Jan 28, 2024 | (FY)Oct 29, 2023 | (Q4)Oct 29, 2023 | (Q3)Jul 30, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 29, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -16.15%50.52B | -28.57%10.83B | -17.31%12.85B | -12.59%15B | -4.44%11.85B | 17.48%60.25B | -0.78%15.16B | 12.21%15.54B | 33.73%17.16B | 32.85%12.4B |
Operating revenue | -16.15%50.52B | -28.57%10.83B | -17.31%12.85B | -12.59%15B | -4.44%11.85B | 17.48%60.25B | -0.78%15.16B | 12.21%15.54B | 33.73%17.16B | 32.85%12.4B |
Cost of revenue | -18.24%31.02B | -29.38%6.82B | -18.45%7.85B | -14.66%9.16B | -9.25%7.2B | 6.72%37.94B | -7.42%9.65B | 1.19%9.62B | 20.32%10.73B | 18.51%7.93B |
Gross profit | -12.60%19.5B | -27.15%4.01B | -15.44%5B | -9.15%5.84B | 4.12%4.65B | 41.81%22.31B | 13.51%5.5B | 36.40%5.91B | 64.31%6.43B | 69.27%4.46B |
Operating expense | 4.58%8.07B | 4.77%1.87B | 8.26%2.11B | -5.13%2.13B | 12.71%1.97B | 15.08%7.72B | 2.24%1.78B | 10.93%1.95B | 30.76%2.24B | 16.87%1.75B |
Selling and administrative expenses | 4.60%4.51B | -1.96%899M | 15.14%1.28B | -4.89%1.27B | 11.97%1.07B | 18.22%4.31B | -5.76%917M | 15.75%1.11B | 42.70%1.33B | 21.90%952M |
-General and administrative expense | 4.60%4.51B | ---- | ---- | ---- | ---- | 18.22%4.31B | ---- | ---- | ---- | ---- |
Research and development costs | 5.19%2.29B | 3.30%626M | 7.39%567M | 3.29%565M | 7.68%533M | 13.86%2.18B | 5.21%606M | 9.77%528M | 20.75%547M | 23.13%495M |
Depreciation amortization depletion | 2.46%874M | ---- | ---- | ---- | ---- | 3.14%853M | ---- | ---- | ---- | ---- |
-Depreciation and amortization | 2.46%874M | ---- | ---- | ---- | ---- | 3.14%853M | ---- | ---- | ---- | ---- |
Other operating expenses | 5.59%397M | 10.42%-533M | -14.84%264M | -18.73%295M | 23.41%369M | 17.50%376M | 6.15%-595M | -1.90%310M | 10.67%363M | -3.86%299M |
Operating profit | -21.68%11.43B | -42.42%2.14B | -27.09%2.89B | -11.29%3.72B | -1.40%2.68B | 61.66%14.59B | 19.83%3.72B | 53.74%3.97B | 90.45%4.19B | 137.83%2.72B |
Net non-operating interest income expense | -36.49%-3.35B | -11.25%-870M | -34.83%-840M | -46.92%-836M | -67.43%-802M | -130.98%-2.45B | -124.07%-782M | -110.47%-623M | -204.28%-569M | -109.17%-479M |
Non-operating interest expense | 36.49%3.35B | 11.25%870M | 34.83%840M | 46.92%836M | 67.43%802M | 130.98%2.45B | 124.07%782M | 110.47%623M | 204.28%569M | 109.17%479M |
Other net income (expense) | 27.92%1.13B | 84.96%246M | 15.15%304M | 3.93%238M | 32.42%339M | -24.25%881M | 3.91%133M | 3.13%264M | -57.59%229M | 7.56%256M |
Gain on sale of security | 160.22%56M | ---- | ---- | ---- | ---- | -144.71%-93M | ---- | ---- | ---- | ---- |
Special income (charges) | -42.42%19M | ---- | ---- | ---- | ---- | -54.17%33M | ---- | ---- | ---- | ---- |
-Less:Other special charges | 42.42%-19M | ---- | ---- | ---- | ---- | 54.17%-33M | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | 11.80%1.05B | -11.40%171M | 15.15%304M | 3.93%238M | 32.42%339M | 6.57%941M | 226.97%193M | 3.13%264M | -57.59%229M | 7.56%256M |
Income before tax | -29.29%9.21B | -50.57%1.52B | -34.69%2.36B | -19.00%3.12B | -11.15%2.22B | 42.64%13.02B | 6.52%3.07B | 42.02%3.61B | 50.78%3.85B | 116.59%2.49B |
Income tax | -27.06%2.09B | -64.78%249M | -1.73%625M | -24.22%751M | -12.66%469M | 43.05%2.87B | 9.95%707M | -2.75%636M | 114.97%991M | 114.80%537M |
Earnings from equity interest net of tax | -442.86%-24M | -1,500.00%-28M | -50.00%1M | 0.00%2M | 100.00%2M | -30.00%7M | 0.00%2M | --2M | -66.67%2M | -66.67%1M |
Net income | -30.20%7.09B | -47.55%1.24B | -41.76%1.73B | -17.17%2.37B | -10.68%1.75B | 42.43%10.16B | 5.53%2.37B | 57.67%2.97B | 36.34%2.86B | 116.48%1.96B |
Net income continuous Operations | -30.20%7.09B | -47.55%1.24B | -41.76%1.73B | -17.17%2.37B | -10.68%1.75B | 42.43%10.16B | 5.53%2.37B | 57.67%2.97B | 36.34%2.86B | 116.48%1.96B |
Minority interest income | -9.09%-12M | -200.00%-3M | 50.00%-3M | -100.00%-2M | -50.00%-3M | -1,000.00%-11M | 50.00%-1M | -700.00%-6M | 0.00%-1M | -300.00%-2M |
Net income attributable to the parent company | -30.16%7.1B | -47.45%1.25B | -41.77%1.73B | -17.13%2.37B | -10.62%1.75B | 42.56%10.17B | 5.48%2.37B | 58.07%2.98B | 36.32%2.86B | 116.94%1.96B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -30.16%7.1B | -47.45%1.25B | -41.77%1.73B | -17.13%2.37B | -10.62%1.75B | 42.56%10.17B | 5.48%2.37B | 58.07%2.98B | 36.32%2.86B | 116.94%1.96B |
Basic earnings per share | -26.06%25.73 | -44.94%4.57 | -38.28%6.32 | -11.66%8.56 | -5.02%6.25 | 48.59%34.8 | 10.96%8.3 | 65.16%10.24 | 41.46%9.69 | 123.81%6.58 |
Diluted earnings per share | -26.02%25.62 | -44.92%4.55 | -38.33%6.29 | -11.61%8.53 | -4.89%6.23 | 48.75%34.63 | 11.02%8.26 | 65.58%10.2 | 41.70%9.65 | 124.32%6.55 |
Dividend per share | 16.44%5.88 | 8.89%1.47 | 17.60%1.47 | 17.60%1.47 | 22.50%1.47 | 15.83%5.05 | 19.47%1.35 | 10.62%1.25 | 19.05%1.25 | 14.29%1.2 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |